Stock Market News for November 10, 2026

At a glance

On November 10, 2026, Sea reported Q3 revenue of US$8.6 billion; Venture Global raised full-year adjusted EBITDA guidance to $10.0–$10.3 billion and said Plaquemines Phase 1 began commercial operations; Beam said its BEACON pivotal trial met its primary efficacy endpoint; CoreWeave raised 2026 revenue outlook to $13.0–$13.3 billion.

Earnings and guidance

Sea (SE) reported third-quarter 2026 results revenue of US$8.6 billion, gross profit of US$3.9 billion and net income of US$502.5 million, with diluted EPS of US$0.78 and Shopee revenue of US$6.1 billion.

Venture Global (VG) reported third-quarter 2026 results revenue of $4.756 billion, net income attributable to common stockholders of $2.546 billion, raised full-year adjusted EBITDA guidance to $10.0–$10.3 billion and said Plaquemines Phase 1 began commercial operations on October 31, 2026.

CoreWeave (CRWV) reported third-quarter 2026 results revenue of $3.661 billion, operating income of $207 million, and raised its 2026 revenue outlook to $13.0 billion–$13.3 billion, while forecasting capital expenditures of $37 billion–$39 billion.

On Holding (ONON) reported third-quarter 2026 results net sales of CHF 931.4 million, net income of CHF 162.8 million and reiterated expected full-year sales growth in the low-20% range at constant currency.

WIX.com (WIX) reported third-quarter 2026 results revenue of $570.2 million, bookings of $573.0 million and maintained 2026 outlook for low- to mid-teens revenue growth while lowering its full-year cash-flow margin outlook.

Astronics (ATRO)oration reported third-quarter 2026 results sales of $271.7 million, record operating income of $54.0 million and net income of $52.2 million, with operating margin of 19.9%.

Liquidia (LQDA) reported third-quarter 2026 results YUTREPIA net product sales of $222.7 million, a GAAP net loss of $236.3 million including a $389.7 million litigation settlement charge, and agreed to net payments of $380.7 million in 2026–2027 under the settlement.

Netlist (NLST) reported third-quarter 2026 results net sales of $105.1 million, including license revenue of $44.9 million, gross margin of 65.5% and net income of $85.4 million.

Drug trials and approvals

Beam Therapeutics (BEAM) announced pivotal BEACON data saying its Phase 1/2 risto-cel trial in sickle cell disease met the primary efficacy endpoint of freedom from severe vaso-occlusive crises for at least 12 consecutive months at the October 20, 2026 cutoff.

PepGen (PEPG) announced Phase 2 FREEDOM2-DM1 results reporting mean splicing correction of 46.5% at 10 mg/kg and functional improvements in hand opening time, grip and mobility with no serious or severe adverse events in the cohort.

Veradermics (MANE) reported third-quarter 2026 results and clinical progress saying Phase 3 Study 304 in men met all primary and secondary endpoints and six-month hair-count increases reached 36.4 hairs/cm² with twice-daily dosing.

Autolus Therapeutics (AUTL) reported third-quarter 2026 results AUCATZYL net product revenue of $41.2 million, narrowed net loss to $55.1 million and reaffirmed full-year 2026 AUCATZYL revenue at or above the prior guidance’s $150 million upper end.

Deals and acquisitions

MaxCyte (MXCT) to acquire Akron Bio under a definitive agreement for $151.8 million in consideration including $105.0 million cash, stock valued at approximately $26.8 million and $20.0 million in guaranteed deferred payments, with closing expected before year-end 2026.

Energy Vault Holdings (NRGV) completed an acquisition and project purchases saying it completed the acquisition of 2.3 GW of U.S. battery storage development projects from Goshe Energy Storage and received grid interconnection approvals, with backlog of $2.3 billion as of November 10, 2026.

Financings and offerings

PepGen (PEPG) announced a proposed public offering launching a proposed $125.0 million public offering of common stock and pre-funded warrants and a 30-day underwriter option for up to an additional $18.75 million.

Prime Medicine (PRME) announced a proposed public offering commencing a proposed underwritten public offering of $125.0 million of common stock, with a 30-day underwriter option to purchase up to an additional $18.75 million.

Aptera Motors (SEV) priced a registered direct offering and private placement for expected gross proceeds of approximately $6 million, selling 3,428,571 Class B common shares at $1.75 per share plus concurrently issued unregistered warrants.

Contracts and partnerships

Redwire (RDW) selected for NASA contract for an approximately $40 million award to adapt its Roll-Out Solar Array technology for a lunar South Pole power-generation demonstration supporting NASA’s Moon Base efforts.

Firefly Aerospace (FLY) signed a multi-launch agreement with Synspective for up to 10 Alpha missions through 2030, each carrying two StriX SAR satellites and deploying up to 20 satellites total from Wallops Pad-0A and Vandenberg SLC-2.

Firefly Aerospace (FLY) reported third-quarter 2026 results with record backlog revenue of $110.682 million, backlog of $1.7 billion, narrowed net loss to $94.198 million and expects full-year revenue of $440 million to $450 million.